Brain+ Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kim Baden-Kristensen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	0.6%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	less than a year

Actualizaciones recientes de la dirección

Recent updates

CEO

Kim Baden-Kristensen

no data

Permanencia

Mr. Kim Baden-Kristensen is Founder, Chief Executive Officer and Managing Director of Brain+ ApS. He is Co-Founder and Chief Executive Officer of Brain+ A/S. He began his career in high tier strategic mana...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Derk Krieger	Chairman of Advisory Board	no data	sin datos	sin datos
Per Luthman	Interim Chairman of the Board	1.6yrs	sin datos	sin datos
Anish Shindore	Director	less than a year	sin datos	sin datos
Tim Juergens	Director	less than a year	sin datos	sin datos

0.5yrs

Permanencia media

Junta con experiencia: La junta directiva de BRAINP no se considera experimentada (0.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Brain+ Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Brain+ A/S, Annual General Meeting, May 15, 2024

Brain+ A/S Announces CFO Changes

Brain+ A/S Announces Resignation of Anders Härfstrand as Chairman and Member of the Board, Effective from January 31, 2024

Brain+ A/S Announces Resignation of Betül Susamis Unaran, Member of the Board of Directors, Effective on 30 November

No independent directors

Brain+ A/S Announces Board Resignation

Recent updates

Brain+ A/S to Report Fiscal Year 2023 Results on Apr 30, 2024

Brain+ A/S, Annual General Meeting, May 15, 2024

Brain+ A/S Announces CFO Changes

Brain+ A/S Announces Resignation of Anders Härfstrand as Chairman and Member of the Board, Effective from January 31, 2024

Brain+ Nominates to CO-PI Grant of Up to DKK 3.5 Million from Denmark's Business Promotion Board

Brain+ A/S Announces Resignation of Betül Susamis Unaran, Member of the Board of Directors, Effective on 30 November

Brain+ A/S Releases New Version of Its Cst-Therapist Companion Dementia Product with Updated User Features

Brain+ Secures Intellectual Property Rights for CST-Therapist Companion in the Eu and the United Kingdom

Brain+ A/S Provides Earnings Guidance for the Full Year 2023

Brain+ A/S Announces Breakthrough Alzheimer's Drug Approval Seen to Renew Dementia Drug Investments and Increase the Potential for Digital Dementia Therapeutics

No independent directors

Brain+ A/S Announces Board Resignation

Brain+ A/S Completes Swedish Research Version of Its Dementia Product with the Research Institutes of Sweden and Extends the Collaboration

Brain+ A/S Announces Results from Clinical Study Provide Promising Feasibility Indications for Brain+' CCT Technology for Cognitive Training

Brain+ A/S Announces 3-Year Innovation Project with the Danish Life Science Cluster Is Completed with the Brain+ CST-Therapist Companion Product as the Final Output

Less than half of directors are independent

Brain+ Announces Board Appointments

Brain+ Announces Its First Digital Dementia Product, Cognitive Stimulation Therapy (CST)-Therapist Companion

Less than half of directors are independent

Brain+ A/S Approves Board Changes

Brain+' New Digital Product for Dementia, “CST-Therapist Companion” Is Ready for Commercial Launch in Denmark

Brain+ A/S Announces Retirement of Jonas Nilsen from the Board

Kim Arvid Nielsen Decides to Step Down from the Board of Brain+ A/S

Paula Petcu Joins Brain+ as New Chief Technology Officer

Brain+ A/S Announces Publication of Results from an Earlier Study That Showed Cognitive Improvements in People with Brain Injury After Training with Brain+ Recover Computerized Cognitive Training Product

Positive Results from the First of Four Clinical Studies to Evaluate Brain+' Starry Night Cognitive Test for Early Detection of Alzheimer's Disease

Brain+ A/S Appoints Bertil S. Jessen as Chief Financial Officer, Effective March 1, 2022

CEO

Permanencia

Miembros de la Junta

Permanencia media